Elanco Animal Health Beats Q2 Earnings Estimates but Faces Increasing Headwinds

Elanco Animal Health (NYSE: ELAN) didn't have much exciting news when the company reported its first-quarter results in May. Revenue was down 1% and adjusted earnings had dropped 23%.

But there was some better news -- and some bad news -- when Elanco announced its second-quarter results before the market opened on Tuesday.